UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 22, 2019
SOLAREDGE TECHNOLOGIES, INC
(Exact name of registrant as specified in its charter)
| | | | | |
Delaware
| | 001-36894
| | 20-5338862
|
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | | |
| 1 Hamada Street, Herziliya Pituach, Israel | | 4673335
|
| (Address of Principal executive offices) | | (Zip Code) |
Registrant’s Telephone number, including area code: 972 (9) 957-6620
Not Applicable
(Former name or former address, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common stock, par value $0.0001 per share
| SEDG
| Nasdaq Global Select Market
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2 below):
☐
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Appointment of Acting Chief Executive Officer
On August 21, 2019, SolarEdge Technologies, Inc. (the “Company”) appointed Mr. Zvi (Zivi) Lando, to serve as Acting Chief Executive Officer. Mr. Lando is replacing Mr. Guy Sella who has taken a leave of absence effective immediately, to address his health issues.
Mr. Lando has served as EVP Global Sales since joining SolarEdge in 2009. Prior to joining SolarEdge, Mr. Lando held several different technology and management positions at Applied Materials, including in his last role, as Vice President and General Manager of Baccini Cell Systems Division in the Applied Materials Solar Business Group.
The Company also updated that in the past few days, Mr. Guy Sella’s previously disclosed health condition has declined significantly.
| 9.01 | Financial Statements and Exhibits. |
| Exhibit No. | Description |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | SOLAREDGE TECHNOLOGIES, INC. |
| | |
| Date: August 22, 2019 | By: /s/ Rachel Prishkolnik |
| | Name: Rachel Prishkolnik Title: General Counsel and Corporate Secretary |
